DeepMed Research

Center for Research in Security Prices, LLC

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Genetics of Cardiovascular and Neuromuscular Disease

Recruiting

Conditions: Cardiomyopathy
Muscular Dystrophy
Arrhythmia

First Posted Date: 2005-08-30

Last Posted Date: 2024-07-26

Lead Sponsor: University of Chicago

Target Recruit Count: 2000

Registration Number: NCT00138931

Locations: 🇺🇸
University of Chicago, Chicago, Illinois, United States

A Pilot Study Comparing the Efficacy of Group Versus Individual Anger Management in Subjects With IED

Phase 2

Completed

Conditions: Anger
Intermittent Explosive Disorder

First Posted Date: 2005-08-05

Last Posted Date: 2013-09-05

Lead Sponsor: University of Chicago

Target Recruit Count: 72

Registration Number: NCT00127400

Locations: 🇺🇸
The University of Chicago, Chicago, Illinois, United States

A Study to Tailor Advance Directives

Completed

Conditions: Dementia
Persistent Vegetative State
Terminally Ill

First Posted Date: 2005-07-19

Last Posted Date: 2013-09-05

Lead Sponsor: University of Chicago

Target Recruit Count: 100

Registration Number: NCT00121004

Locations: 🇺🇸
The University of Chicago, Chicago, Illinois, United States

The Addition of Montelukast to Fluticasone in the Treatment of Perennial Allergic Rhinitis

Phase 4

Terminated

Conditions: Rhinitis, Allergic, Perennial

Interventions: Drug: Placebo
Drug: Montelukast
Drug: Fluticasone propionate

First Posted Date: 2005-07-12

Last Posted Date: 2014-02-28

Lead Sponsor: University of Chicago

Target Recruit Count: 102

Registration Number: NCT00119015

Locations: 🇺🇸
The University of Chicago, Chicago, Illinois, United States

Nasal Ocular Reflexes Contribute to Eye Symptoms

Not Applicable

Completed

Conditions: Rhinitis, Allergic, Seasonal

First Posted Date: 2005-07-08

Last Posted Date: 2013-09-05

Lead Sponsor: University of Chicago

Target Recruit Count: 20

Registration Number: NCT00117832

Locations: 🇺🇸
University of Chicago, Chicago, Illinois, United States

Docetaxel Based Chemotherapy Plus or Minus Induction Chemotherapy to Decrease Events in Head and Neck Cancer (DeCIDE)

Phase 3

Completed

Conditions: Cancer of the Pharynx
Cancer of the Larynx
Cancer of the Nasal Cavity
Paranasal Sinus Neoplasms
Cancer of the Oral Cavity

Interventions: Drug: docetaxel
Drug: cisplatin
Drug: hydroxyurea
Drug: fluorouracil
Procedure: chemotherapy
Procedure: radiotherapy

First Posted Date: 2005-07-07

Last Posted Date: 2018-04-09

Lead Sponsor: University of Chicago

Target Recruit Count: 285

Registration Number: NCT00117572

Locations: 🇭🇷
University Hospital for Tumors Zagreb, Zagreb, Croatia
🇺🇸
Joliet Oncology Hematology Associates, Joliet, Illinois, United States
🇺🇸
University of Kansas Cancer Center, Kansas City, Kansas, United States

and more 23 locations

Xolair in Patients With Chronic Sinusitis

Phase 4

Completed

Conditions: Sinusitis

Interventions: Drug: Anti-IgE antibody omalizumab or placebo

First Posted Date: 2005-07-07

Last Posted Date: 2013-09-30

Lead Sponsor: University of Chicago

Target Recruit Count: 14

Registration Number: NCT00117611

Locations: 🇺🇸
The University of Chicago, Chicago, Illinois, United States

A Pilot Study of the Mechanism of Synergism Between FP and Salmeterol in Preventing COPD Exacerbations

Phase 1

Completed

Conditions: Pulmonary Disease, Chronic Obstructive

Interventions: Drug: fluticasone and salmeterol

First Posted Date: 2005-06-29

Last Posted Date: 2014-08-05

Lead Sponsor: University of Chicago

Target Recruit Count: 15

Registration Number: NCT00116402

Locations: 🇺🇸
Department of Medicine, Pulmonary & Critical Care Section, The University of Chicago, Chicago, Illinois, United States

Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Epithelial Ovarian Cancer or Primary Peritoneal Cancer

Phase 1

Completed

Conditions: Ovarian Cancer
Primary Peritoneal Cavity Cancer

Interventions: Biological: filgrastim
Drug: amifostine trihydrate
Drug: carboplatin
Drug: cyclophosphamide
Procedure: peripheral blood stem cell transplantation

First Posted Date: 2004-08-24

Last Posted Date: 2013-02-11

Lead Sponsor: University of Chicago

Target Recruit Count: 11

Registration Number: NCT00003136

Locations: 🇺🇸
University of Chicago Cancer Research Center, Chicago, Illinois, United States

Irofulven in Treating Patients With Metastatic or Recurrent Colorectal Cancer

Phase 2

Withdrawn

Conditions: Colorectal Cancer

Interventions: Drug: irofulven

First Posted Date: 2004-08-04

Last Posted Date: 2014-03-07

Lead Sponsor: University of Chicago

Registration Number: NCT00003786

Locations: 🇺🇸
University of Illinois at Chicago, Chicago, Illinois, United States
🇺🇸
Michiana Hematology/Oncology P.C., South Bend, Indiana, United States
🇺🇸
University of Chicago Cancer Research Center, Chicago, Illinois, United States

and more 6 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy